Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

FATE $5.27 1.5700 +42.43%
ADXS $5.61 0.7500 +15.43%
ZIOP $4.80 0.5300 +12.41%
CVM $0.65 0.0657 +11.24%
ISIS $65.09 5.5400 +9.30%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

IMGN $6.11 -4.7400 -43.69%
CBMG $12.55 -1.1400 -8.33%
GTXI $0.89 -0.0800 -8.25%
PARD $0.16 -0.0100 -5.88%
GLYC $8.64 -0.4200 -4.64%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | Next > | Last >>

After Colon Cancer, Activity Is Linked to Better Survival

(Reuters Health) Dec 9, 2014 - More leisure activity - like tennis or jogging – and less TV-time after a colon cancer diagnosis was linked with better survival in a new study.
read article 



Quality of Life at Diagnosis May Predict Survival for Patients With Aggressive Lymphoma

(Mayo Clinic) Dec 7, 2014 - Self-reported quality of life among patients diagnosed with aggressive lymphoma can predict overall survival and event-free survival, a Mayo Clinic study has found. The results were presented today at the 56th American Society of Hematology annual meeting, in San Francisco.
read press release 



Simple Blood Test Could Aid Early Breast Cancer Detection

(UPI.com) Dec 9, 2014 - A team of researchers led by Oxford University say they've developed a technique that could allow doctors to detect breast cancer tumors using a simple blood test.
read article 



Mayo Clinic: Genotyping Errors Plague CYP2D6 Testing for Tamoxifen Therapy

(Mayo Clinic) Dec 9, 2014 - Clinical recommendations discouraging the use of CYP2D6 gene testing to guide tamoxifen therapy in breast cancer patients are based on studies with flawed methodology and should be reconsidered, according to the results of a Mayo Clinic study published in the Journal of the National Cancer Institute.
read press release 



Analysis Shows Increased Use of Hypofractionated Whole-Breast Irradiation for Patients with Early-Stage Breast Cancer

(ASTRO) Dec 9, 2014 - The use of hypofractionated whole-breast irradiation (HF-WBI) for patients with early-stage breast cancer increased 17.4 percent from 2004 to 2011, and patients are more likely to receive HF-WBI compared to conventionally fractionated whole-breast irradiation (CF-WBI) when they are treated at an academic center or live more than 50 miles away from a cancer center, according to a study.
read press release 



Women with Dense Breasts Will Have to Look Beyond Ultrasound for Useful Supplemental Breast Cancer Screening

(Dartmouth-Hitchcock/Norris Cotton CC) Dec 9, 2014 - Supplemental ultrasound screening for all U.S. women with dense breasts would substantially increase healthcare costs with little improvement in overall health.
read press release 



Genomic Health Announces Presentation of First Prospective Outcomes Study of Oncotype DX(R) Breast Cancer Test

(Austin Business Journal) Dec 10, 2014 - Genomic Health, Inc. today announced early results from Europe's largest contemporary adjuvant breast cancer trial, which used the Oncotype DX® breast cancer test to identify higher-risk patients who would benefit from the treatment.
read article 



Pittsburgh Researchers Discover Mutation That Spreads Breast Cancer

(Pittsburgh Post-Gazette) Dec 10, 2014 - A team of Pittsburgh researchers has discovered a genetic mutation that aided the spread of breast cancer in a patient, an exciting discovery that may provide guidance for how to treat women with the disease in the future, according to a study announced today at a breast cancer symposium in San Antonio.
read article 



New Drug Combination for Advanced Breast Cancer Delays Disease Progression

(Yale News) Dec 10, 2014 - A new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer, according to a multi-center phase II trial.
read article 



Male Breast Cancer Is Different

(Philadelphia Inquirer/HealthDay News) Dec 9, 2014 - Men's breast cancer differs in some ways from women's, new research finds.
read article 



Adding Ultrasound to Routine Mammography Improves Cancer Detection in Dense Breasts

(AACR) Dec 9, 2014 - The number of breast cancers detected in women with dense breasts was increased when those women who had a normal mammogram underwent an additional breast ultrasound screening, according to data presented at the 2014 San Antonio Breast Cancer Symposium, held Dec. 9–13.
read press release 



Immunotherapy Drug Pembrolizumab Safe for Patients With Triple-negative Breast Cancer, Effective in Some

(AACR) Dec 10, 2014 - A phase Ib clinical trial to evaluate the efficacy and tolerability of pembrolizumab in patients with metastatic triple-negative breast cancer showed the drug was well tolerated and yielded durable responses, according to data presented at the 2014 San Antonio Breast Cancer Symposium, held Dec. 9–13.
read press release 



FERGI Trial: New Questions About PI3K Inhibition in Breast Cancer

(Medscape Medical News) Dec 10, 2014 - Results of the first phase 2 trial to evaluate a PI3 kinase inhibitor in ER–positive breast cancer are in.
read article (free registration required) 



High Tumor Immune Cell Levels May ID Women With HER2-positive Breast Cancer Who Might Benefit From Chemo Alone

(AACR) Dec 10, 2014 - Women with HER2-positive breast cancer who had high levels of immune cells in their tumors had a decreased risk of cancer recurrence after treatment with chemotherapy alone compared with their counterparts who had low levels of tumor-infiltrating immune cells, according to data presented at the 2014 San Antonio Breast Cancer Symposium, held Dec. 9–13.
read press release 



International Breast Cancer Study Group, Breast International Group and Merck Announce Opening of International PANACEA Study of Patients with HER2+ Breast Cancer

(MarketWatch) Dec 10, 2014 - Collaborative trial is first to investigate an anti-PD-1 therapy, pembrolizumab, combined with trastuzumab; study to explore whether new approach may reverse trastuzumab resistance in cancer with significant unmet need.
read article 



Lung Cancer Patients Say Don't Blame Us, Fund Us

(Bloomberg) Dec 9, 2014 - New drugs still aren’t an option for most lung cancer patients. The majority of those with the diseases have mutations that fall into tiny subsets of less than 2 percent of the total, a consequence of the many carcinogens in tobacco. Drugs haven’t been developed to fight them.
read article 



Long Radiation Treatments Faulted in Many Breast Cancer Cases

(New York Times) Dec 10, 2014 - Two-thirds of women who have lumpectomies for breast cancer are getting radiation treatment that lasts nearly twice as long as necessary, a new study reports.
read article 



Merck Drug Shrank Tumors in Some Breast Cancer Patients in Trial

(Wall Street Journal) Dec 10, 2014 - A Merck & Co. drug shrank tumors in about 18.5% of women with an aggressive form of breast cancer in a small clinical trial, an early sign of the potential of immunotherapy to treat breast tumors.
read article (paid subscription required) 



From AARP to Pfizer, Partners Seek Optum Labs Big Data to Improve Health

(Forbes) Dec 8, 2014 - A health care research initiative using tens of millions of health insurance claims and electronic health records is forming myriad partnerships with business, employers and the health care industry to improve health outcomes and potentially lower costs.
read article 



Lilly Rheumatoid Arthritis Drug Meets Goals in Final-Stage Trial

(Bloomberg) Dec 9, 2014 - Eli Lilly & Co. and Incyte Corp.’s experimental drug helped patients with rheumatoid arthritis in a late-stage trial, the company said.
read article 



FDA Advisers’ Financial Ties Not Disclosed

(NASDAQ/Dow Jones Business News) Dec 8, 2014 - David Kandzari, an Atlanta cardiologist, also has worked as a consultant to makers of medical devices. He received at least $100,000 from them in five years, according to corporate and government data.
read article 



Can CMS 'Concessions' Save Medicare ACOs?

(MedPage Today) Dec 8, 2014 - Proposed rules for Medicare accountable care organizations (ACOs), released on Monday, offer concessions to try to avert a threatened exodus of ACOs from the federal program.
read article (free registration required) 



Juno Therapeutics Sets IPO at 9.25 Million Shares

(Wall Street Journal) Dec 9, 2014 - Juno Therapeutics Inc. said Tuesday that it hopes to raise up to $166.5 million in its initial public offering, one of the mostly highly anticipated biotech offerings for the coming year.
read article (paid subscription required) 



Smoking Still Causes Large Proportion of Cancer Deaths in the United States

(American Cancer Society) Dec 9, 2014 - A new American Cancer Society study finds that despite significant drops in smoking rates, cigarettes continue to cause about three in ten cancer deaths in the United States. The study, appearing in the Annals of Epidemiology, concludes that efforts to reduce smoking prevalence as rapidly as possible should be a top priority for the U.S. public health efforts to prevent cancer deaths.
read press release 



Flatiron Health and Vector Oncology to Offer Patient-Reported Outcomes at the Point of Care

(TheStreet) Dec 9, 2014 - Flatiron Health and Vector Oncology today announced a partnership that enables oncology providers to easily gather and view patient-reported symptoms at the point of care by using Vector Oncology's Patient Care Monitor™ integrated with OncoEMR®.
read article